{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T18:05:00Z","timestamp":1789495500944,"version":"build-2803163510"},"reference-count":63,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T00:00:00Z","timestamp":1789430400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Ministry of Finance of Saudi Arabia","award":["P179873 and P512986"],"award-info":[{"award-number":["P179873 and P512986"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:sec id=\"sec001\">\n                    <jats:title>Background and aims<\/jats:title>\n                    <jats:p>Insufficient physical activity contributes to the global rise of metabolic dysfunction\u2013associated steatotic liver disease (MASLD). Although physical activity levels in Saudi Arabia have increased in recent years, MASLD shows an increasing prevalence trend, affecting over 30% of the population. This study aimed to determine the impact of increased physical activity, and resulting reduction in hepatic steatosis, on the projected health and economic burden of MASLD in Saudi Arabia.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec002\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We simulated MASLD progression from 2025 to 2045 using a validated Markov model. Three aspirational physical activity intervention scenarios were evaluated, assuming that 10%, 20%, and 30% of individuals with MASLD achieved a clinically significant \u226530% relative reduction in hepatic steatosis. Health outcomes were measured in disability-adjusted life years (DALYs), and economic outcomes were analyzed using U.S.-based direct healthcare costs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec003\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>MASLD prevalence in Saudi Arabia is projected to increase from approximately 10.0 million in 2025 to 14.3 million in 2045. In scenarios where 10%, 20%, and 30% of individuals with MASLD achieved a\u2009\u2265\u200930% reduction in hepatic steatosis, cumulative liver-related deaths are projected to decline by 4.3%\u201312.3%, hepatocellular carcinoma cases by 4.9%\u201314.2%, and decompensated cirrhosis cases by up to 14.0%. Direct health care costs are estimated to reduce by 4.0%\u201311.5%, and DALYs are projected to decline by 8.6%\u201324.2% across scenarios.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec004\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Increased physical activity could significantly reduce the future health and economic impacts of MASLD in Saudi Arabia. Achieving a\u2009\u2265\u200930% reduction in hepatic steatosis among individuals with MASLD could reduce liver-related complications, deaths, DALYs, and healthcare costs. These findings support the integration of MASLD-specific outcomes into national physical activity promotion campaigns and noncommunicable disease advocacy efforts, aligned with Saudi Vision 2030.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1371\/journal.pone.0354332","type":"journal-article","created":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T17:35:17Z","timestamp":1789493717000},"page":"e0354332","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["Modelling the impact of physical activity on MASLD in Saudi Arabia"],"prefix":"10.1371","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-0940-4498","authenticated-orcid":true,"given":"Carolyn","family":"Wallace","sequence":"first","affiliation":[{"name":"Center for Disease Analysis Foundation","place":["Lafayette, Colorado, United States of America"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saleh A.","family":"Alessy","sequence":"additional","affiliation":[{"name":"Saudi Electronic University","place":["Riyadh, Saudi Arabia"],"department":["Department of Public Health"]},{"name":"Liver, Digestive, and Lifestyle Health Research Section, King Faisal Specialist Hospital and Research Center","place":["Riyadh, Saudi Arabia"]},{"name":"King\u2019s College London","place":["London"],"department":["Center for Cancer, Society and Public Health, Faculty of Life Sciences and Medicine"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faisal","family":"Abaalkhail","sequence":"additional","affiliation":[{"name":"Gastroenterology Section, King Faisal Specialist Hospital and Research Center","place":["Riyadh, Saudi Arabia"],"department":["Department of Medicine"]},{"name":"College of Medicine, Alfaisal University","place":["Riyadh, Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saad","family":"Alghamdi","sequence":"additional","affiliation":[{"name":"Organ Transplant Center of Excellence, King Faisal Specialist Hospital & Research Center","place":["Riyadh, Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4792-5188","authenticated-orcid":true,"given":"Assim A.","family":"Alfadda","sequence":"additional","affiliation":[{"name":"College of Medicine, King Saud University","place":["Riyadh, Saudi Arabia"],"department":["Obesity Research Center, and the Department of Medicine"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulrahman","family":"Al Qabbani","sequence":"additional","affiliation":[{"name":"King Faisal Specialist Hospital and Research Center","place":["Riyadh, Saudi Arabia"],"department":["Department of Medicine, Section of Endocrinology"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fadiah","family":"Alkhattabi","sequence":"additional","affiliation":[{"name":"College of Medicine, Alfaisal University","place":["Riyadh, Saudi Arabia"]},{"name":"King Faisal Specialist Hospital and Research Center","place":["Riyadh, Saudi Arabia"],"department":["Department of Pediatrics"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reem S.","family":"AlAhmed","sequence":"additional","affiliation":[{"name":"Liver, Digestive, and Lifestyle Health Research Section, King Faisal Specialist Hospital and Research Center","place":["Riyadh, Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1250-7234","authenticated-orcid":true,"given":"Tagreed A.","family":"Mazi","sequence":"additional","affiliation":[{"name":"College of Applied Medical Sciences, King Saud University","place":["Riyadh, Saudi Arabia"],"department":["Department of Community Health Sciences \u2013 Clinical Nutrition"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamdan","family":"Alghamdi","sequence":"additional","affiliation":[{"name":"Hepatology Section, Hepatobiliary Sciences and Organs Transplant Center, King Abdulaziz Medical City","place":["Riyadh, Saudi Arabia"]},{"name":"King Saud Bin Abdulaziz University for Health Sciences, Ministry of National Guard Health Affairs","place":["Riyadh, Saudi Arabia"]},{"name":"King Abdullah International Research Center, Ministry of National Guard Health Affairs","place":["Riyadh, Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-0013-5253","authenticated-orcid":true,"given":"Sadeem","family":"Aldarwesh","sequence":"additional","affiliation":[{"name":"Liver, Digestive, and Lifestyle Health Research Section, King Faisal Specialist Hospital and Research Center","place":["Riyadh, Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoug","family":"Alashmali","sequence":"additional","affiliation":[{"name":"King Abdulaziz University","place":["Jeddah, Saudi Arabia"],"department":["Department of Clinical Nutrition"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rowaedh A.","family":"Bawaked","sequence":"additional","affiliation":[{"name":"Saudi Electronic University","place":["Riyadh, Saudi Arabia"],"department":["Department of Public Health"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khalid","family":"Alobthani","sequence":"additional","affiliation":[{"name":"King Faisal Specialist Hospital and Research Center","place":["Riyadh, Saudi Arabia"],"department":["Physical Rehabilitation Department"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4733-4289","authenticated-orcid":true,"given":"Bandar","family":"Al-Judaibi","sequence":"additional","affiliation":[{"name":"Organ Transplant Center of Excellence, King Faisal Specialist Hospital & Research Center","place":["Riyadh, Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Waleed K.","family":"Al-Hamoudi","sequence":"additional","affiliation":[{"name":"Organ Transplant Center of Excellence, King Faisal Specialist Hospital & Research Center","place":["Riyadh, Saudi Arabia"]},{"name":"Liver Disease Research Center, College of Medicine, King Saud University","place":["Riyadh, Saudi Arabia"],"department":["Department of Medicine"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitri A.","family":"Raptis","sequence":"additional","affiliation":[{"name":"Organ Transplant Center of Excellence, King Faisal Specialist Hospital & Research Center","place":["Riyadh, Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brandon","family":"Eurich","sequence":"additional","affiliation":[{"name":"Center for Disease Analysis Foundation","place":["Lafayette, Colorado, United States of America"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Homie","family":"Razavi","sequence":"additional","affiliation":[{"name":"Center for Disease Analysis Foundation","place":["Lafayette, Colorado, United States of America"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-5468-1355","authenticated-orcid":true,"given":"Predrag","family":"Zivotic","sequence":"additional","affiliation":[{"name":"World Bank Group","place":["Washington, District of Columbia, United States of America"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5401-3614","authenticated-orcid":true,"given":"Severin","family":"Rakic","sequence":"additional","affiliation":[{"name":"World Bank Group","place":["Washington, District of Columbia, United States of America"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Volkan","family":"Cetinkaya","sequence":"additional","affiliation":[{"name":"World Bank Group","place":["Washington, District of Columbia, United States of America"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2017-3526","authenticated-orcid":true,"given":"Saleh A.","family":"Alqahtani","sequence":"additional","affiliation":[{"name":"Liver, Digestive, and Lifestyle Health Research Section, King Faisal Specialist Hospital and Research Center","place":["Riyadh, Saudi Arabia"]},{"name":"Organ Transplant Center of Excellence, King Faisal Specialist Hospital & Research Center","place":["Riyadh, Saudi Arabia"]},{"name":"Weill Cornell Medicine","place":["New York, United States of America"],"department":["Division of Gastroenterology and Hepatology"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2026,9,15]]},"reference":[{"issue":"6","key":"pone.0354332.ref001","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1159\/000533301","article-title":"How Could Different Obesity Scenarios Alter the Burden of Type 2 Diabetes and Liver Disease in Saudi Arabia?","volume":"16","author":"T Coker","year":"2023","journal-title":"Obes Facts"},{"issue":"7","key":"pone.0354332.ref002","doi-asserted-by":"crossref","DOI":"10.1111\/obr.13448","article-title":"Prevalence, risk factors, and interventions for obesity in Saudi Arabia: A systematic review","volume":"23","author":"V Salem","year":"2022","journal-title":"Obes Rev"},{"key":"pone.0354332.ref003","unstructured":"World Health Organization. Global Health Observatory. Database. https:\/\/www.who.int\/data\/gho\/data\/2025 2024. Accessed 2025."},{"key":"pone.0354332.ref004","unstructured":"Alqahtani SA, Alotaibi HF, AlMuhaidib S, Barakeh D, Abaalkhail F, Alessy SA. Nationwide assessment of metabolic dysfunction-associated steatotic liver disease (MASLD) prevalence in Saudi Arabia: Insights from the GENESIS population-based cohort study. In: Hepatology, Washington, DC, USA, 2025. S1156\u20137."},{"issue":"4","key":"pone.0354332.ref005","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1097\/HEP.0000000000000004","article-title":"The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review","volume":"77","author":"ZM Younossi","year":"2023","journal-title":"Hepatology"},{"issue":"4","key":"pone.0354332.ref006","doi-asserted-by":"crossref","first-page":"211","DOI":"10.4103\/sjg.SJG_122_18","article-title":"Nonalcoholic fatty liver disease burden - Saudi Arabia and United Arab Emirates, 2017-2030","volume":"24","author":"K Alswat","year":"2018","journal-title":"Saudi J Gastroenterol"},{"issue":"12","key":"pone.0354332.ref007","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0338438","article-title":"Metabolic dysfunction-associated steatohepatitis is the leading indication for adult liver transplantation in Saudi Arabia","volume":"20","author":"SA Alqahtani","year":"2025","journal-title":"PLoS One"},{"issue":"2","key":"pone.0354332.ref008","doi-asserted-by":"crossref","first-page":"104","DOI":"10.4103\/sjg.sjg_199_25","article-title":"Metabolic dysfunction-associated steatotic liver disease management in Saudi Arabia: A modified Delphi-based adaptation of international standards","volume":"32","author":"F Abaalkhail","year":"2026","journal-title":"Saudi J Gastroenterol"},{"issue":"5","key":"pone.0354332.ref009","doi-asserted-by":"crossref","first-page":"310","DOI":"10.4103\/sjg.sjg_62_24","article-title":"The burden of metabolic dysfunction-associated steatotic liver disease and viral hepatitis in Saudi Arabia","volume":"30","author":"SA Alqahtani","year":"2024","journal-title":"Saudi J Gastroenterol"},{"issue":"12","key":"pone.0354332.ref010","doi-asserted-by":"crossref","DOI":"10.1111\/liv.70390","article-title":"Cost of Metabolic Dysfunction-Associated Steatotic Liver Disease Screening Among All People Living With Diabetes in Six Countries","volume":"45","author":"JV Lazarus","year":"2025","journal-title":"Liver Int"},{"key":"pone.0354332.ref011","doi-asserted-by":"crossref","unstructured":"Alqahtani SA, Albarakah Y, Ahmed M, Abu-Esba L, Alabdulkarim H, Abaalkhail F. EE579: Micro-Costing Analysis of the Economic Burden of Metabolic Dysfunction-Associated Steatohepatitis and Its Comorbidities in Saudi Arabia. In: Value in Health, Glasgow, Scotland, 2025.","DOI":"10.1016\/j.jval.2025.09.961"},{"key":"pone.0354332.ref012","unstructured":"Saudi Vision 2030. Health Sector Transformation Program. 2025. https:\/\/www.vision2030.gov.sa\/en\/explore\/programs\/health-sector-transformation-program"},{"issue":"4","key":"pone.0354332.ref013","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0297278","article-title":"Health and economic burden of insufficient physical activity in Saudi Arabia","volume":"19","author":"SA Alqahtani","year":"2024","journal-title":"PLoS One"},{"key":"pone.0354332.ref014","doi-asserted-by":"crossref","first-page":"1236287","DOI":"10.3389\/fpubh.2023.1236287","article-title":"Comprehensive assessment of physical activity policies and initiatives in Saudi Arabia 2016-2022","volume":"11","author":"MA AlMarzooqi","year":"2023","journal-title":"Front Public Health"},{"issue":"1","key":"pone.0354332.ref015","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1186\/s12889-025-22631-5","article-title":"Stakeholder perspectives on surveillance of physical activity and monitoring and evaluation of interventions in Saudi Arabia","volume":"25","author":"HM Al-Hazzaa","year":"2025","journal-title":"BMC Public Health"},{"key":"pone.0354332.ref016","volume-title":"Physical Activity Statistics Bulletin","author":"Saudi Arabia General Authority for Statistics","year":"2024"},{"issue":"6","key":"pone.0354332.ref017","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1123\/jpah.2022-0537","article-title":"Scoping Review of Population-Based Physical Activity and Sedentary Behavior in Saudi Arabia","volume":"20","author":"KR Evenson","year":"2023","journal-title":"J Phys Act Health"},{"issue":"11","key":"pone.0354332.ref018","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1038\/s41591-022-02012-w","article-title":"Association of step counts over time with the risk of chronic disease in the All of Us Research Program","volume":"28","author":"H Master","year":"2022","journal-title":"Nat Med"},{"key":"pone.0354332.ref019","first-page":"360257","article-title":"Physical activity plays an important role in body weight regulation","volume":"2011","author":"J-P Chaput","year":"2011","journal-title":"J Obes"},{"issue":"2","key":"pone.0354332.ref020","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3727\/105221617X15124844266408","article-title":"The Effects of Physical Exercise on Fatty Liver Disease","volume":"18","author":"DJ van der Windt","year":"2018","journal-title":"Gene Expr"},{"issue":"7","key":"pone.0354332.ref021","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.14309\/ajg.0000000000002098","article-title":"Exercise Training Is Associated With Treatment Response in Liver Fat Content by Magnetic Resonance Imaging Independent of Clinically Significant Body Weight Loss in Patients With Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis","volume":"118","author":"JG Stine","year":"2023","journal-title":"Am J Gastroenterol"},{"key":"pone.0354332.ref022","doi-asserted-by":"crossref","first-page":"94","DOI":"10.14740\/jocmr5113","article-title":"Barriers to Exercise in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease: A Patient Survey","volume":"16","author":"K Deshpande","year":"2024","journal-title":"J Clin Med Res"},{"issue":"10","key":"pone.0354332.ref023","doi-asserted-by":"crossref","first-page":"3604","DOI":"10.1007\/s10620-020-06673-w","article-title":"Breaking Down Barriers to Physical Activity in Patients with Nonalcoholic Fatty Liver Disease","volume":"66","author":"JG Stine","year":"2021","journal-title":"Dig Dis Sci"},{"issue":"8","key":"pone.0354332.ref024","doi-asserted-by":"crossref","DOI":"10.1111\/liv.70226","article-title":"\u201cWeekend Warrior\u201d Exercise Pattern Protects Against MASLD and Mortality Comparable to Regular Exercise: National Cohort Study","volume":"45","author":"S Zelber-Sagi","year":"2025","journal-title":"Liver Int"},{"issue":"4","key":"pone.0354332.ref025","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.cgh.2014.04.014","article-title":"Fibrosis progression in nonalcoholic fatty liver vs nonalcoholic steatohepatitis: a systematic review and meta-analysis of paired-biopsy studies","volume":"13","author":"S Singh","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"8","key":"pone.0354332.ref026","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1016\/j.cgh.2023.04.005","article-title":"Liver transplantation 2023: status report, current and future challenges","volume":"21","author":"NA Terrault","year":"2023","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"11","key":"pone.0354332.ref027","doi-asserted-by":"crossref","first-page":"2274","DOI":"10.1016\/j.cgh.2020.08.061","article-title":"Change in MRI-PDFF and Histologic Response in Patients With Nonalcoholic Steatohepatitis: A Systematic Review and Meta-Analysis","volume":"19","author":"JG Stine","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"5","key":"pone.0354332.ref028","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1136\/gutjnl-2021-324264","article-title":"Clinical utility of 30% relative decline in MRI-PDFF in predicting fibrosis regression in non-alcoholic fatty liver disease","volume":"71","author":"N Tamaki","year":"2022","journal-title":"Gut"},{"issue":"9","key":"pone.0354332.ref029","doi-asserted-by":"crossref","first-page":"2368","DOI":"10.1111\/liv.15947","article-title":"Exercise improves surrogate measures of liver histological response in metabolic dysfunction-associated steatotic liver disease","volume":"44","author":"DJ Cuthbertson","year":"2024","journal-title":"Liver Int"},{"issue":"10213","key":"pone.0354332.ref030","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1016\/S0140-6736(19)32517-6","article-title":"Resmetirom (MGL-3196) for the treatment of non-alcoholic steatohepatitis: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial","volume":"394","author":"SA Harrison","year":"2019","journal-title":"Lancet"},{"issue":"6","key":"pone.0354332.ref031","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1249\/MSS.0000000000001938","article-title":"Physical Activity and the Prevention of Weight Gain in Adults: A Systematic Review","volume":"51","author":"JM Jakicic","year":"2019","journal-title":"Med Sci Sports Exerc"},{"issue":"3","key":"pone.0354332.ref032","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.3821","article-title":"Physical Activity and Incident Obesity Across the Spectrum of Genetic Risk for Obesity","volume":"7","author":"EL Brittain","year":"2024","journal-title":"JAMA Netw Open"},{"issue":"3","key":"pone.0354332.ref033","doi-asserted-by":"crossref","first-page":"100263","DOI":"10.1016\/j.jhepr.2021.100263","article-title":"Physical activity is associated with reduced risk of liver disease in the prospective UK Biobank cohort","volume":"3","author":"CV Schneider","year":"2021","journal-title":"JHEP Rep"},{"issue":"6","key":"pone.0354332.ref034","article-title":"Physical Activity Is Associated With Nonalcoholic Fatty Liver Disease and Significant Fibrosis Measured by FibroScan","volume":"20","author":"D Kim","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"pone.0354332.ref035","unstructured":"International Monetary Fund. Consumer Price Index (CPI). https:\/\/data.imf.org\/en 2025. Accessed 2023."},{"key":"pone.0354332.ref036","volume-title":"WHO methods and data sources for global burden of disease estimates 2000-2019","author":"World Health Organization","year":"2020"},{"key":"pone.0354332.ref037","volume-title":"Global Burden of Disease Study 2015 (GBD 2015) Disability Weights","author":"Global Burden of Disease Collaborative Network","year":"2016"},{"key":"pone.0354332.ref038","unstructured":"World Bank G. GDP per capita. https:\/\/data.worldbank.org\/indicator\/NY.GDP.PCAP.CD?locations=SA 2025. Accessed 2023."},{"key":"pone.0354332.ref039","doi-asserted-by":"crossref","DOI":"10.1016\/S0618-8278(19)30006-4","article-title":"GS-06-positive results from REGENERATE: a phase 3 international, randomized, placebo-controlled study evaluating obeticholic acid treatment for NASH","volume":"70","author":"Z Younossi","year":"2019","journal-title":"J Hepatol"},{"key":"pone.0354332.ref040","doi-asserted-by":"crossref","unstructured":"Gal P, Roiz J, Xiao Y. Calibrating Model-Consistent Transition Probabilities for Fibrosis Stages in NASH. In: ISPOR 20th Annual European Congress; 2017 November 4-8, 2017. Glasgow, Scotland, 2017.","DOI":"10.1016\/j.jval.2017.08.2118"},{"issue":"11","key":"pone.0354332.ref041","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1007\/s00125-024-06196-3","article-title":"EASL-EASD-EASO Clinical Practice Guidelines on the Management of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): Executive Summary","volume":"67","author":"European Association for the Study of the Liver, European Association for the Study of Diabetes, European Association for the Study of Obesity","year":"2024","journal-title":"Diabetologia"},{"issue":"5","key":"pone.0354332.ref042","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1097\/HEP.0000000000000323","article-title":"AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease","volume":"77","author":"ME Rinella","year":"2023","journal-title":"Hepatology"},{"issue":"4","key":"pone.0354332.ref043","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.jhep.2016.05.026","article-title":"Effect of exercise on the development of new fatty liver and the resolution of existing fatty liver","volume":"65","author":"K-C Sung","year":"2016","journal-title":"J Hepatol"},{"issue":"1","key":"pone.0354332.ref044","doi-asserted-by":"crossref","first-page":"19992","DOI":"10.1038\/s41598-021-99036-y","article-title":"A weight regain of 1.5 kg or more and lack of exercise are associated with nonalcoholic fatty liver disease recurrence in men","volume":"11","author":"N Nakanishi","year":"2021","journal-title":"Sci Rep"},{"issue":"12","key":"pone.0354332.ref045","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1038\/ijo.2016.123","article-title":"Exercise-induced improvements in liver fat and endothelial function are not sustained 12 months following cessation of exercise supervision in nonalcoholic fatty liver disease","volume":"40","author":"CJA Pugh","year":"2016","journal-title":"Int J Obes (Lond)"},{"issue":"3","key":"pone.0354332.ref046","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1111\/jgh.13965","article-title":"Physical activity levels and hepatic steatosis: A longitudinal follow-up study in adults","volume":"33","author":"AM Gerage","year":"2018","journal-title":"J Gastroenterol Hepatol"},{"issue":"1","key":"pone.0354332.ref047","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s12966-020-00978-9","article-title":"Systematic review of the prospective association of daily step counts with risk of mortality, cardiovascular disease, and dysglycemia","volume":"17","author":"KS Hall","year":"2020","journal-title":"Int J Behav Nutr Phys Act"},{"issue":"10","key":"pone.0354332.ref048","doi-asserted-by":"crossref","first-page":"102995","DOI":"10.1016\/j.isci.2021.102995","article-title":"Obesity treatment: Weight loss versus increasing fitness and physical activity for reducing health risks","volume":"24","author":"GA Gaesser","year":"2021","journal-title":"iScience"},{"issue":"10431","key":"pone.0354332.ref049","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/S0140-6736(23)02750-2","article-title":"Worldwide trends in underweight and obesity from 1990 to 2022: a pooled analysis of 3663 population-representative studies with 222 million children, adolescents, and adults","volume":"403","author":"NCD Risk Factor Collaboration NCD-Risc","year":"2024","journal-title":"Lancet"},{"key":"pone.0354332.ref050","volume-title":"World Health Survey Saudi Arabia","author":"Saudi Arabia Ministry of Health","year":"2019"},{"key":"pone.0354332.ref051","volume-title":"Health Determinants Statistics Publication, National Health Survey","author":"Saudi Arabia General Authority for Statistics","year":"2024"},{"issue":"1","key":"pone.0354332.ref052","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1093\/aje\/kws448","article-title":"Prevalence of nonalcoholic fatty liver disease in the United States: the Third National Health and Nutrition Examination Survey, 1988-1994","volume":"178","author":"M Lazo","year":"2013","journal-title":"Am J Epidemiol"},{"key":"pone.0354332.ref053","article-title":"Nonalcoholic fatty liver disease without cirrhosis is an emergent and independent risk factor of hepatocellular carcinoma: A population based study","volume":"56","author":"RN Rahman","year":"2012","journal-title":"Hepatology"},{"issue":"6","key":"pone.0354332.ref054","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1002\/hep.28123","article-title":"Association of nonalcoholic fatty liver disease (NAFLD) with hepatocellular carcinoma (HCC) in the United States from 2004 to 2009","volume":"62","author":"ZM Younossi","year":"2015","journal-title":"Hepatology"},{"issue":"4","key":"pone.0354332.ref055","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1002\/hep.21103","article-title":"Similarities and differences in outcomes of cirrhosis due to nonalcoholic steatohepatitis and hepatitis C","volume":"43","author":"AJ Sanyal","year":"2006","journal-title":"Hepatology"},{"key":"pone.0354332.ref056","volume-title":"SEER survival monograph: Cancer survival among adults: U.S. SEER program, 1988-2001, patient and tumor characteristics","author":"L Ries","year":"2007"},{"key":"pone.0354332.ref057","doi-asserted-by":"crossref","first-page":"102731","DOI":"10.1016\/j.canep.2024.102731","article-title":"Liver cancer in Saudi Arabia: A registry-based nationwide descriptive epidemiological and survival analysis","volume":"94","author":"NH Almohammadi","year":"2025","journal-title":"Cancer Epidemiol"},{"issue":"1","key":"pone.0354332.ref058","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgast-2024-001577","article-title":"Burden of five major types of gastrointestinal cancer in the Eastern Mediterranean Region","volume":"12","author":"SA Alessy","year":"2025","journal-title":"BMJ Open Gastroenterol"},{"key":"pone.0354332.ref059","doi-asserted-by":"crossref","unstructured":"Alqahtani S, Alessy S, Vignat J, Al-Zahrani A, Bray F, Znaor A. Current pattern and future projections of primary liver cancer in the Gulf Cooperation Council countries: analysis from GLOBOCAN 2020 database. The Liver Meeting, American Association for the Study of Liver Diseases. Boston, MA; 2023.","DOI":"10.1016\/S0016-5085(24)02684-2"},{"key":"pone.0354332.ref060","unstructured":"IRODaT. International Registry on Organ Donation and Transplantation. https:\/\/irodat.org\/ 2025."},{"issue":"1","key":"pone.0354332.ref061","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/s12916-024-03315-0","article-title":"Global epidemiology of type 2 diabetes in patients with NAFLD or MAFLD: a systematic review and meta-analysis","volume":"22","author":"L Cao","year":"2024","journal-title":"BMC Med"},{"issue":"6","key":"pone.0354332.ref062","doi-asserted-by":"crossref","first-page":"426","DOI":"10.4103\/sjg.sjg_73_22","article-title":"Transient elastography for the prevalence of non-alcoholic fatty liver disease in patients with type 2 diabetes: Evidence from the CORDIAL cohort study","volume":"28","author":"AA Alfadda","year":"2022","journal-title":"Saudi J Gastroenterol"},{"issue":"6","key":"pone.0354332.ref063","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1002\/hep.26218","article-title":"Chronic hepatitis C virus (HCV) disease burden and cost in the United States","volume":"57","author":"H Razavi","year":"2013","journal-title":"Hepatology"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0354332","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T17:35:29Z","timestamp":1789493729000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0354332"}},"subtitle":[],"editor":[{"given":"Muhammad Salman","family":"Bashir","sequence":"first","affiliation":[{"name":"King Fahad Medical City","place":["SAUDI ARABIA"]}],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,9,15]]},"references-count":63,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,9,15]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0354332","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,15]]}}}